These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 30866762)
1. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Schloer S; Goretzko J; Kühnl A; Brunotte L; Ludwig S; Rescher U Emerg Microbes Infect; 2019; 8(1):80-93. PubMed ID: 30866762 [TBL] [Abstract][Full Text] [Related]
2. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression. Schräder T; Dudek SE; Schreiber A; Ehrhardt C; Planz O; Ludwig S Antiviral Res; 2018 Sep; 157():80-92. PubMed ID: 29990517 [TBL] [Abstract][Full Text] [Related]
3. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication. Perwitasari O; Yan X; O'Donnell J; Johnson S; Tripp RA Assay Drug Dev Technol; 2015 Dec; 13(10):638-49. PubMed ID: 26192013 [TBL] [Abstract][Full Text] [Related]
4. Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein. Meutiawati F; Bezemer B; Strating JRPM; Overheul GJ; Žusinaite E; van Kuppeveld FJM; van Cleef KWR; van Rij RP Antiviral Res; 2018 Sep; 157():68-79. PubMed ID: 29981375 [TBL] [Abstract][Full Text] [Related]
5. Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection. Saha P; Saha R; Datta Chaudhuri R; Sarkar R; Sarkar M; Koley H; Chawla-Sarkar M Viruses; 2024 Aug; 16(8):. PubMed ID: 39205291 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice. Betts RJ; Mann TS; Henry PJ J Pharmacol Exp Ther; 2012 Dec; 343(3):725-35. PubMed ID: 22988062 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of influenza virus replication by plant-derived isoquercetin. Kim Y; Narayanan S; Chang KO Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184 [TBL] [Abstract][Full Text] [Related]
8. Ethanol Extract of Zhang L; Chen J; Ke C; Zhang H; Zhang S; Tang W; Liu C; Liu G; Chen S; Hu A; Sun W; Xiao Y; Liu M; Chen X Viruses; 2020 May; 12(5):. PubMed ID: 32443510 [TBL] [Abstract][Full Text] [Related]
9. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures. Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M Front Immunol; 2019; 10():60. PubMed ID: 30761132 [TBL] [Abstract][Full Text] [Related]
10. Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection. Schloer S; Goretzko J; Pleschka S; Ludwig S; Rescher U Viruses; 2020 Jun; 12(7):. PubMed ID: 32610711 [TBL] [Abstract][Full Text] [Related]
11. Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics. Ulyanova V; Shah Mahmud R; Laikov A; Dudkina E; Markelova M; Mostafa A; Pleschka S; Ilinskaya O Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167434 [TBL] [Abstract][Full Text] [Related]
12. Transient inhibition of sphingosine kinases confers protection to influenza A virus infected mice. Xia C; Seo YJ; Studstill CJ; Vijayan M; Wolf JJ; Hahm B Antiviral Res; 2018 Oct; 158():171-177. PubMed ID: 30125617 [TBL] [Abstract][Full Text] [Related]
13. A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Li P; Cui Q; Wang L; Zhao X; Zhang Y; Manicassamy B; Yang Y; Rong L; Du R Viruses; 2018 Jun; 10(6):. PubMed ID: 29899269 [TBL] [Abstract][Full Text] [Related]
14. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment. Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207 [TBL] [Abstract][Full Text] [Related]
15. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs. Chen SC; Jeng KS; Lai MMC J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860 [TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Droebner K; Pleschka S; Ludwig S; Planz O Antiviral Res; 2011 Nov; 92(2):195-203. PubMed ID: 21854809 [TBL] [Abstract][Full Text] [Related]
17. Posaconazole inhibits multiple steps of the alphavirus replication cycle. Varghese FS; Meutiawati F; Teppor M; Jacobs S; de Keyzer C; Taşköprü E; van Woudenbergh E; Overheul GJ; Bouma E; Smit JM; Delang L; Merits A; van Rij RP Antiviral Res; 2022 Jan; 197():105223. PubMed ID: 34856248 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-146a inhibits influenza A virus replication by enhancing the type I interferon response in vitro and in vivo. Zhang F; Sun X; Zhu Y; Qin W Biomed Pharmacother; 2019 Mar; 111():740-750. PubMed ID: 30611999 [TBL] [Abstract][Full Text] [Related]
19. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway. Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053 [TBL] [Abstract][Full Text] [Related]
20. Germacrone inhibits early stages of influenza virus infection. Liao Q; Qian Z; Liu R; An L; Chen X Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]